{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T14:36:41Z","timestamp":1721227001118},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T00:00:00Z","timestamp":1439596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T00:00:00Z","timestamp":1439596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10637-015-0275-x","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:27:01Z","timestamp":1439512021000},"page":"1020-1031","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-beta"],"prefix":"10.1007","volume":"33","author":[{"given":"Laurent-Olivier","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Belle","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,15]]},"reference":[{"issue":"Suppl 5","key":"275_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","volume":"14","author":"TA Dolecek","year":"2012","unstructured":"Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009. Neuro-Oncology 14(Suppl 5):v1\u2013v49","journal-title":"Neuro-Oncology"},{"key":"275_CR2","unstructured":"Fritz A, Percy C, Jack A, Shanmugaratnam K, Parkin DM, Whelan S (2012) International Classification of Diseases for Oncology, 3rd edn. Publication of the World Health Organization 1\u2013250"},{"key":"275_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff R-O, Groups EOFRATOCBTARO, National Cancer Institute of Canada Clinical Trials Group (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5\u00a0years analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466","journal-title":"Lancet Oncol"},{"key":"275_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756\u2013760","journal-title":"Nature"},{"key":"275_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1476-4598-10-128","volume":"10","author":"D Beier","year":"2011","unstructured":"Beier D, Schulz JB, Beier CP (2011) Chemoresistance of glioblastoma cancer stem cells--much more complex than expected. Mol Cancer 10:128","journal-title":"Mol Cancer"},{"key":"275_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","volume":"4","author":"A-M Bleau","year":"2009","unstructured":"Bleau A-M, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, Holland EC (2009) PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4:226\u2013235","journal-title":"Cell Stem Cell"},{"key":"275_CR7","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC-H, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu I-M, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA, Hartigan J, Smith DR, Strausberg RL, Marie SKN, Shinjo SMO, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807\u20131812","journal-title":"Science"},{"key":"275_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, Groups EOFRATOCBTAR, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"275_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28935","author":"KM Field","year":"2014","unstructured":"Field KM, Jordan JT, Wen PY, Rosenthal MA, Reardon DA (2014) Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies. Cancer. doi:10.1002\/cncr.28935","journal-title":"Cancer"},{"key":"275_CR10","first-page":"5143","volume":"60","author":"T Kilic","year":"2000","unstructured":"Kilic T, Alberta JA, Zdunek PR, Acar M, Iannarelli P, O\u2019Reilly T, Buchdunger E, Black PM, Stiles CD (2000) Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res 60:5143\u20135150","journal-title":"Cancer Res"},{"key":"275_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1177\/1947601912450586","volume":"2","author":"DA Reardon","year":"2012","unstructured":"Reardon DA, Cheresh D (2012) Cilengitide: a prototypic integrin inhibitor for the treatment of glioblastoma and other malignancies. Genes Cancer 2:1159\u20131165. doi:10.1177\/1947601912450586","journal-title":"Genes Cancer"},{"key":"275_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/neuonc\/nos117","volume":"14","author":"PY Wen","year":"2012","unstructured":"Wen PY, Lee EQ, Reardon DA, Ligon KL, Alfred Yung WK (2012) Current clinical development of PI3K pathway inhibitors in glioblastoma. Neuro-Oncology 14:819\u2013829. doi:10.1093\/neuonc\/nos117","journal-title":"Neuro-Oncology"},{"key":"275_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1479-5876-12-13","volume":"12","author":"P Jiang","year":"2014","unstructured":"Jiang P, Mukthavaram R, Mukthavavam R, Chao Y, Bharati IS, Fogal V, Pastorino S, Cong X, Nomura N, Gallagher M, Abbasi T, Vali S, Pingle SC, Makale M, Kesari S (2014) Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs. J Transl Med 12:13. doi:10.1186\/1479-5876-12-13","journal-title":"J Transl Med"},{"key":"275_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/neuonc\/nou118","volume":"16","author":"R Rahman","year":"2014","unstructured":"Rahman R, Hempfling K, Norden AD, Reardon DA, Nayak L, Rinne ML, Beroukhim R, Doherty L, Ruland S, Rai A, Rifenburg J, LaFrankie D, Alexander BM, Huang RY, Wen PY, Lee EQ (2014) Retrospective study of carmustine or lomustine with Bevacizumab in recurrent glioblastoma patients who have failed prior Bevacizumab. Neuro-Oncology 16:1523\u20131529. doi:10.1093\/neuonc\/nou118","journal-title":"Neuro-Oncology"},{"key":"275_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.surneu.2006.08.080","volume":"67","author":"E Brice\u00f1o","year":"2007","unstructured":"Brice\u00f1o E, Calderon A, Sotelo J (2007) Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme. Surg Neurol 67:388\u2013391. doi:10.1016\/j.surneu.2006.08.080","journal-title":"Surg Neurol"},{"key":"275_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/neuonc\/nop046","volume":"12","author":"EL Kim","year":"2010","unstructured":"Kim EL, W\u00fcstenberg R, R\u00fcbsam A, Schmitz-Salue C, Warnecke G, B\u00fccker E-M, Pettkus N, Speidel D, Rohde V, Schulz-Schaeffer W, Deppert W, Giese A (2010) Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells. Neuro-Oncology 12:389\u2013400. doi:10.1093\/neuonc\/nop046","journal-title":"Neuro-Oncology"},{"key":"275_CR17","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1158\/0008-5472.CAN-11-3831","volume":"72","author":"YL Hu","year":"2012","unstructured":"Hu YL, DeLay M, Jahangiri A, Molinaro AM, Rose SD, Carbonell WS, Aghi MK (2012) Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 72:1773\u20131783. doi:10.1158\/0008-5472.CAN-11-3831","journal-title":"Cancer Res"},{"key":"275_CR18","doi-asserted-by":"publisher","DOI":"10.4161\/mco.29911","author":"G Manic","year":"2014","unstructured":"Manic G, Obrist F, Kroemer G, Vitale I (2014) Chloroquine and hydroxychloroquine for cancer therapy. Mol Cell. doi:10.4161\/mco.29911","journal-title":"Mol Cell"},{"key":"275_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1357-2725(97)00128-3","volume":"30","author":"DA Clark","year":"1998","unstructured":"Clark DA, Coker R (1998) Transforming growth factor-beta (TGF-beta). Int J Biochem Cell Biol 30:293\u2013298","journal-title":"Int J Biochem Cell Biol"},{"key":"275_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0002-9440(10)63970-3","volume":"158","author":"CM Dubois","year":"2001","unstructured":"Dubois CM, Blanchette F, Laprise M-H, Leduc R, Grondin F, Seidah NG (2001) Evidence that furin is an authentic transforming growth factor-\u03b21-converting enzyme. Am J Pathol 158:305\u2013316","journal-title":"Am J Pathol"},{"key":"275_CR21","doi-asserted-by":"publisher","first-page":"10618","DOI":"10.1074\/jbc.270.18.10618","volume":"270","author":"CM Dubois","year":"1995","unstructured":"Dubois CM, Laprise M-H, Blanchette F, Gentry LE, Leduc R (1995) Processing of transforming growth factor b1 precusor by human furin convertase. J Biol Chem 270:10618\u201310624","journal-title":"J Biol Chem"},{"key":"275_CR22","doi-asserted-by":"publisher","first-page":"7596","DOI":"10.1158\/0008-5472.CAN-04-1627","volume":"64","author":"MA Friese","year":"2004","unstructured":"Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A, Weller M (2004) RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res 64:7596\u20137603","journal-title":"Cancer Res"},{"key":"275_CR23","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1158\/0008-5472.CAN-12-0546","volume":"72","author":"ME Hardee","year":"2012","unstructured":"Hardee ME, Marciscano AE, Medina-Ramirez CM, Zagzag D, Narayana A, Lonning SM, Barcellos-Hoff MH (2012) Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-\u03b2. Cancer Res 72:4119\u20134129","journal-title":"Cancer Res"},{"key":"275_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1359-6101(96)00048-2","volume":"8","author":"MS Pepper","year":"1997","unstructured":"Pepper MS (1997) Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21\u201343","journal-title":"Cytokine Growth Factor Rev"},{"key":"275_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0092-8674(04)00298-3","volume":"117","author":"J Seoane","year":"2004","unstructured":"Seoane J, Le H-V, Shen L, Anderson SA, Massagu\u00e9 J (2004) Integration of smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117:211\u2013223","journal-title":"Cell"},{"key":"275_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1023\/A:1012209518843","volume":"53","author":"W Wick","year":"2001","unstructured":"Wick W, Platten M, Weller M (2001) Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neuro-Oncol 53:177\u2013185","journal-title":"J Neuro-Oncol"},{"key":"275_CR27","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.4049\/jimmunol.148.5.1404","volume":"148","author":"DB Constam","year":"1992","unstructured":"Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A (1992) Differential expression of transforming growth factor-beta 1, \u2212beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol 148:1404\u20131410","journal-title":"J Immunol"},{"key":"275_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5","volume":"89","author":"C Kjellman","year":"2000","unstructured":"Kjellman C, Olofsson SP, Hansson O, Von Schantz T, Lindvall M, Nilsson I, Salford LG, Sj\u00f6gren HO, Widegren B (2000) Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int J Cancer 89:251\u2013258","journal-title":"Int J Cancer"},{"key":"275_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11523-014-0308-y","volume":"10","author":"L-O Roy","year":"2015","unstructured":"Roy L-O, Poirier M-B, Fortin D (2015) Transforming growth factor-beta and its implication in the malignancy of gliomas. Target Oncol 10:1\u201314. doi:10.1007\/s11523-014-0308-y","journal-title":"Target Oncol"},{"key":"275_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ccr.2010.10.023","volume":"18","author":"J Anido","year":"2010","unstructured":"Anido J, S\u00e1ez-Border\u00edas A, Gonz\u00e0lez-Junc\u00e0 A, Rod\u00f3n L, Folch G, Carmona MA, Prieto-SAnchez RM, Barba I, Mart\u00ednez-S\u00e1ez E, Prudkin L, Cuartas I, Ravent\u00f3s C, Mart\u00ednez-Ricarte F, Poca MA, GarcIa-Dorado D, Lahn MM, Yingling JM, Rod\u00f3n J, Sahuquillo J, Baselga J, Seoane J (2010) TGF-beta receptor inhibitors target the CD44high\/Id1high glioma-initiating cell population in human glioblastoma. Cancer Cell 18:655\u2013668. doi:10.1016\/j.ccr.2010.10.023","journal-title":"Cancer Cell"},{"key":"275_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1005863419880","volume":"36","author":"MT Jennings","year":"1998","unstructured":"Jennings MT, Pietenpol JA (1998) The role of transforming growth factor beta in glioma progression. J Neuro-Oncol 36:123\u2013140","journal-title":"J Neuro-Oncol"},{"key":"275_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccr.2009.02.011","volume":"15","author":"S Pe\u00f1uelas","year":"2009","unstructured":"Pe\u00f1uelas S, Anido J, Prieto-SAnchez RM, Folch G, Barba I, Cuartas I, GarcIa-Dorado D, Poca MA, Sahuquillo J, Baselga J, Seoane J (2009) TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15:315\u2013327. doi:10.1016\/j.ccr.2009.02.011","journal-title":"Cancer Cell"},{"key":"275_CR33","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1124\/mol.65.3.744","volume":"65","author":"SD Byfield","year":"2004","unstructured":"Byfield SD, Major C, Laping NJ (2004) SB-505124 is a selective inhibitor of transforming growth factor-\u03b2 type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 65:744\u2013752","journal-title":"Mol Pharmacol"},{"key":"275_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1089\/oli.2005.15.94","volume":"15","author":"R Schlingensiepen","year":"2005","unstructured":"Schlingensiepen R, Goldbrunner M, Szyrach MNI, Stauder G, Jachimczak P, Bogdahn U, Schulmeyer F, Hau P, Schlingensiepen K-H (2005) Intracerebral and intrathecal infusion of the TGF-\u03b22-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety. Oligonucleotides 15:94\u2013104","journal-title":"Oligonucleotides"},{"key":"275_CR35","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1158\/1078-0432.CCR-09-1067","volume":"15","author":"R Ueda","year":"2009","unstructured":"Ueda R, Fujita M, Zhu X, Sasaki K, Kastenhuber ER, Kohanbash G, McDonald HA, Harper J, Lonning S, Okada H (2009) Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines. Clin Cancer Res 15:6551\u20136559","journal-title":"Clin Cancer Res"},{"key":"275_CR36","doi-asserted-by":"publisher","first-page":"7954","DOI":"10.1158\/0008-5472.CAN-04-1013","volume":"64","author":"M Uhl","year":"2004","unstructured":"Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ying Ma J, Almirez R, Mangadu R, Liu Y-W, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M (2004) SD-208, a novel transforming growth factor receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res 64:7954\u20137961","journal-title":"Cancer Res"},{"key":"275_CR37","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/sj.bjc.6990291","volume":"79","author":"PA Forsyth","year":"1999","unstructured":"Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G, Edwards DR (1999) Gelatinase-a (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79:1828\u20131835. doi:10.1038\/sj.bjc.6690291","journal-title":"Br J Cancer"},{"key":"275_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/09553002.2012.692495","volume":"88","author":"G Desmarais","year":"2012","unstructured":"Desmarais G, Fortin D, Bujold R, Wagner R, Mathieu D, Paquette B (2012) Infiltration of glioma cells in brain parenchyma stimulated by radiation in the F98\/fischer rat model. Int J Radiat Biol 88:565\u2013574","journal-title":"Int J Radiat Biol"},{"key":"275_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492\u2013507. doi:10.1056\/NEJMra0708126","journal-title":"N Engl J Med"},{"key":"275_CR40","doi-asserted-by":"publisher","first-page":"18443","DOI":"10.1074\/jbc.273.29.18443","volume":"273","author":"SJ Duguay","year":"1998","unstructured":"Duguay SJ, Jin Y, Stein J, Duguay AN, Gardner P, Steiner DF (1998) Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J Biol Chem 273:18443\u201318451","journal-title":"J Biol Chem"},{"key":"275_CR41","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1021\/cr010168i","volume":"102","author":"NC Rockwell","year":"2002","unstructured":"Rockwell NC, Krysan DJ, Komiyama T, Fuller RS (2002) Precursor processing by Kex2\/furin proteases. Chem Rev 102:4525\u20134548. doi:10.1021\/cr010168i","journal-title":"Chem Rev"},{"key":"275_CR42","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1471-4159.2004.02806.x","volume":"91","author":"W Wick","year":"2004","unstructured":"Wick W, Wild-Bode C, Frank B, Weller M (2004) BCL-2-induced glioma cell invasiveness depends on furin-like proteases. J Neurochem 91:1275\u20131283. doi:10.1111\/j.1471-4159.2004.02806.x","journal-title":"J Neurochem"},{"key":"275_CR43","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/415686a","volume":"415","author":"RG Ridley","year":"2002","unstructured":"Ridley RG (2002) Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 415:686\u2013693. doi:10.1038\/415686a","journal-title":"Nature"},{"key":"275_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/538481","volume":"2012","author":"F Shujatullah","year":"2012","unstructured":"Shujatullah F, Khan HM, Khatoon A, Khan PA, Ashfaq M (2012) In vitro chloroquine resistance in plasmodium falciparum isolates from tertiary care hospital. Malar Res Treat 2012:1\u20134. doi:10.1016\/S1473-3099(10)70214-0","journal-title":"Malar Res Treat"},{"key":"275_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.148","volume":"3","author":"K-S Chan","year":"2012","unstructured":"Chan K-S, Koh C-G, Li H-Y (2012) Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis 3, e411. doi:10.1038\/cddis.2012.148","journal-title":"Cell Death Dis"},{"key":"275_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047357","volume":"7","author":"E Firat","year":"2012","unstructured":"Firat E, Weyerbrock A, Gaedicke S, Grosu A-L, Niedermann G (2012) Chloroquine or chloroquine-PI3K\/Akt pathway inhibitor combinations strongly promote \u03b3-irradiation-induced cell death in primary stem-like glioma cells. PLoS ONE 7, e47357. doi:10.1371\/journal.pone.0047357","journal-title":"PLoS ONE"},{"key":"275_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccr.2007.04.001","volume":"11","author":"H Zhang","year":"2007","unstructured":"Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, Dang CV, Semenza GL (2007) HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11:407\u2013420. doi:10.1016\/j.ccr.2007.04.001","journal-title":"Cancer Cell"},{"key":"275_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/neuonc\/nop048","volume":"12","author":"Y Geng","year":"2010","unstructured":"Geng Y, Kohli L, Klocke BJ, Roth KA (2010) Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. Neuro-Oncology 12:473\u2013481. doi:10.1093\/neuonc\/nop048","journal-title":"Neuro-Oncology"},{"key":"275_CR49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0165-5728(99)00203-9","volume":"100","author":"AR Dix","year":"1999","unstructured":"Dix AR, Brooks WH, Roszman TL, Morford LA (1999) Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 100:216\u2013232","journal-title":"J Neuroimmunol"},{"key":"275_CR50","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.4049\/jimmunol.146.10.3289","volume":"146","author":"MJ Smyth","year":"1991","unstructured":"Smyth MJ, Strobl SL, Young HA, Ortaldo JR, Ochoa AC (1991) Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8\u2009+\u2009T lymphocytes. Inhibition by transforming growth factor-beta. J Immunol 146:3289\u20133297","journal-title":"J Immunol"},{"key":"275_CR51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2125.1983.tb01532.x","volume":"15","author":"LL Gustafsson","year":"1983","unstructured":"Gustafsson LL, Walker O, Alv\u00e1n G, Beermann B, Estevez F, Gleisner L, Lindstr\u00f6m B, Sj\u00f6qvist F (1983) Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 15:471\u2013479","journal-title":"Br J Clin Pharmacol"},{"key":"275_CR52","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1128\/AAC.02279-12","volume":"58","author":"MM Marques","year":"2013","unstructured":"Marques MM, Costa MRF, Santana Filho FS, Vieira JLF, Nascimento MTS, Brasil LW, Nogueira F, Silveira H, Reyes-Lecca RC, Monteiro WM, Lacerda MVG, Alecrim MGC (2013) Plasmodium vivax chloroquine resistance and anemia in the western Brazilian amazon. Antimicrob Agents Chemother 58:342\u2013347. doi:10.1128\/AAC.02279-12","journal-title":"Antimicrob Agents Chemother"},{"key":"275_CR53","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1128\/AAC.02794-13","volume":"58","author":"S Pukrittayakamee","year":"2014","unstructured":"Pukrittayakamee S, Tarning J, Jittamala P, Charunwatthana P, Lawpoolsri S, Lee SJ, Hanpithakpong W, Hanboonkunupakarn B, Day NPJ, Ashley EA, White NJ (2014) Pharmacokinetic interactions between primaquine and chloroquine. Antimicrob Agents Chemother 58:3354\u20133359. doi:10.1128\/AAC.02794-13","journal-title":"Antimicrob Agents Chemother"},{"key":"275_CR54","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00228-004-0818-0","volume":"60","author":"J Rengelshausen","year":"2004","unstructured":"Rengelshausen J, Burhenne JR, Fr\u00f6hlich M, Tayrouz Y, Singh SK, Riedel K-D, M\u00fcller O, Hoppe-Tichy T, Haefeli WE, Mikus G, Walter-Sack I (2004) Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. Eur J Clin Pharmacol 60:709\u2013715. doi:10.1007\/s00228-004-0818-0","journal-title":"Eur J Clin Pharmacol"},{"key":"275_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.addr.2011.12.008","volume":"64","author":"F Broccatelli","year":"2012","unstructured":"Broccatelli F, Larregieu CA, Cruciani G, Oprea TI, Benet LZ (2012) Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev 64:95\u2013109. doi:10.1016\/j.addr.2011.12.008","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-015-0275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-015-0275-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-015-0275-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-015-0275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:47:10Z","timestamp":1678510030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-015-0275-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,15]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1007\/s10637-015-0275-x","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,15]]},"assertion":[{"value":"7 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}